Local Corticosteroid Injection to Trigger Points in the Short-Term Treatment of Cervicogenic Headache: A Randomized Clinical Trial

Local Corticosteroid Injection to Trigger Points in the Short-Term Treatment of Cervicogenic Headache: A Randomized Clinical Trial - Local corticosteroid injection for cervicogenic headache

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000016049

Enrollment

Registered

2014-12-24

Start date

2014-12-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Interventions

Patients were given a single dose of 20 mg long acting betamethasone (0.5 ml). The mixture was injected at trigger points in paraspinal muscles. All the patients were asked to return gradually to norm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: unilateral, intermittent, and localized pain with moderate to severe intensity on the occipital, frontal, temporal or orbital regions, and lasting hours to days

Exclusion criteria

Exclusion criteria: recent trauma to the head and neck regions

Design outcomes

Primary

Measure	Time frame
for the short-term local corticosteroid injection to trigger points is an effective treatment of cervicogenic headache	—

Countries

Asia(except Japan)

Contacts

Public ContactKamran Azma

Islamic Republic of Iran Army University of Medical Sciences Department of Physical Medicine and Rehabilitation

kamazema@yahoo.com+81-0982122728029

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026